Global and United States Montelukast Drug Market 2020 by Manufacturers, Type and Application, Forecast to 2025
Market Overview
The global Montelukast Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Montelukast Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Montelukast Drug market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Montelukast Drug market has been segmented into Tablet, Chewable tablet, Oral Granules, etc.
Breakdown by Application, Montelukast Drug has been segmented into Hospital, Drug store, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Montelukast Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Montelukast Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Montelukast Drug market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Montelukast Drug Market Share Analysis
Montelukast Drug competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Montelukast Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Montelukast Drug sales, revenue and market share for each player covered in this report.
The major players covered in Montelukast Drug are: Merck & Co., Lannett Company, Glenmark Pharmaceuticals, Teva, Torrent Pharmaceuticals, Mylan, Dr. Reddys Laboratories, Sandoz, Hikma Group, Apotex, Ajanta Pharma, Unichem Laboratories, Aurobindo Pharma, Shanghai Anbison Lab, MACLEODS, Unimark, Accord Healthcare, Amneal Pharmaceuticals, Jubilant Pharma, Hetero, Perrigo, Cipla, CSPC Ouyi Pharmaceutical, etc. Among other players domestic and global, Montelukast Drug market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Montelukast Drug market are listed below:
Merck & Co.
Lannett Company
Glenmark Pharmaceuticals
Teva
Torrent Pharmaceuticals
Mylan
Dr. Reddys Laboratories
Sandoz
Hikma Group
Apotex
Ajanta Pharma
Unichem Laboratories
Aurobindo Pharma
Shanghai Anbison Lab
MACLEODS
Unimark
Accord Healthcare
Amneal Pharmaceuticals
Jubilant Pharma
Hetero
Perrigo
Cipla
CSPC Ouyi Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Tablet
Chewable tablet
Oral Granules
Market segment by Application, can be divided into
Hospital
Drug store
Others
Table of Contents
1 Market Overview
1.1 Montelukast Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Montelukast Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tablet
1.2.3 Chewable tablet
1.2.4 Oral Granules
1.3 Market Analysis by Application
1.3.1 Overview: Global Montelukast Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drug store
1.3.4 Others
1.4 Global Montelukast Drug Market Size and Forecast (2015-2025)
1.4.1 Global Montelukast Drug Revenue and Forecast (2015-2025)
1.4.2 Global Montelukast Drug Sales and Forecast (2015-2025)
1.5 Global Montelukast Drug Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck & Co. SWOT Analysis
2.1.4 Merck & Co. Product and Services
2.1.5 Merck & Co. Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lannett Company
2.2.1 Lannett Company Details
2.2.2 Lannett Company Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lannett Company SWOT Analysis
2.2.4 Lannett Company Product and Services
2.2.5 Lannett Company Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Glenmark Pharmaceuticals
2.3.1 Glenmark Pharmaceuticals Details
2.3.2 Glenmark Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Glenmark Pharmaceuticals SWOT Analysis
2.3.4 Glenmark Pharmaceuticals Product and Services
2.3.5 Glenmark Pharmaceuticals Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Torrent Pharmaceuticals
2.5.1 Torrent Pharmaceuticals Details
2.5.2 Torrent Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Torrent Pharmaceuticals SWOT Analysis
2.5.4 Torrent Pharmaceuticals Product and Services
2.5.5 Torrent Pharmaceuticals Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mylan SWOT Analysis
2.6.4 Mylan Product and Services
2.6.5 Mylan Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Dr. Reddys Laboratories
2.7.1 Dr. Reddys Laboratories Details
2.7.2 Dr. Reddys Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Dr. Reddys Laboratories SWOT Analysis
2.7.4 Dr. Reddys Laboratories Product and Services
2.7.5 Dr. Reddys Laboratories Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sandoz
2.8.1 Sandoz Details
2.8.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sandoz SWOT Analysis
2.8.4 Sandoz Product and Services
2.8.5 Sandoz Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Hikma Group
2.9.1 Hikma Group Details
2.9.2 Hikma Group Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Hikma Group SWOT Analysis
2.9.4 Hikma Group Product and Services
2.9.5 Hikma Group Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Apotex
2.10.1 Apotex Details
2.10.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Apotex SWOT Analysis
2.10.4 Apotex Product and Services
2.10.5 Apotex Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ajanta Pharma
2.11.1 Ajanta Pharma Details
2.11.2 Ajanta Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ajanta Pharma SWOT Analysis
2.11.4 Ajanta Pharma Product and Services
2.11.5 Ajanta Pharma Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Unichem Laboratories
2.12.1 Unichem Laboratories Details
2.12.2 Unichem Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Unichem Laboratories SWOT Analysis
2.12.4 Unichem Laboratories Product and Services
2.12.5 Unichem Laboratories Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Aurobindo Pharma
2.13.1 Aurobindo Pharma Details
2.13.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Aurobindo Pharma SWOT Analysis
2.13.4 Aurobindo Pharma Product and Services
2.13.5 Aurobindo Pharma Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Shanghai Anbison Lab
2.14.1 Shanghai Anbison Lab Details
2.14.2 Shanghai Anbison Lab Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Shanghai Anbison Lab SWOT Analysis
2.14.4 Shanghai Anbison Lab Product and Services
2.14.5 Shanghai Anbison Lab Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 MACLEODS
2.15.1 MACLEODS Details
2.15.2 MACLEODS Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 MACLEODS SWOT Analysis
2.15.4 MACLEODS Product and Services
2.15.5 MACLEODS Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Unimark
2.16.1 Unimark Details
2.16.2 Unimark Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Unimark SWOT Analysis
2.16.4 Unimark Product and Services
2.16.5 Unimark Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Accord Healthcare
2.17.1 Accord Healthcare Details
2.17.2 Accord Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Accord Healthcare SWOT Analysis
2.17.4 Accord Healthcare Product and Services
2.17.5 Accord Healthcare Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Amneal Pharmaceuticals
2.18.1 Amneal Pharmaceuticals Details
2.18.2 Amneal Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Amneal Pharmaceuticals SWOT Analysis
2.18.4 Amneal Pharmaceuticals Product and Services
2.18.5 Amneal Pharmaceuticals Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Jubilant Pharma
2.19.1 Jubilant Pharma Details
2.19.2 Jubilant Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Jubilant Pharma SWOT Analysis
2.19.4 Jubilant Pharma Product and Services
2.19.5 Jubilant Pharma Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Hetero
2.20.1 Hetero Details
2.20.2 Hetero Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Hetero SWOT Analysis
2.20.4 Hetero Product and Services
2.20.5 Hetero Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 Perrigo
2.21.1 Perrigo Details
2.21.2 Perrigo Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Perrigo SWOT Analysis
2.21.4 Perrigo Product and Services
2.21.5 Perrigo Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 Cipla
2.22.1 Cipla Details
2.22.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Cipla SWOT Analysis
2.22.4 Cipla Product and Services
2.22.5 Cipla Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.23 CSPC Ouyi Pharmaceutical
2.23.1 CSPC Ouyi Pharmaceutical Details
2.23.2 CSPC Ouyi Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 CSPC Ouyi Pharmaceutical SWOT Analysis
2.23.4 CSPC Ouyi Pharmaceutical Product and Services
2.23.5 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Montelukast Drug Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Montelukast Drug Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Montelukast Drug Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: United States
3.2.1 Key Players Montelukast Drug Sales in United States (2018-2019)
3.2.2 United States Montelukast Drug Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Montelukast Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Montelukast Drug Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Montelukast Drug Market Size by Geography (2015-2020)
4.1.1 Global Montelukast Drug Sales by Geography (2015-2020)
4.1.2 Global Montelukast Drug Revenue by Regions (2015-2020)
4.2 Global Montelukast Drug Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Montelukast Drug Sales and Forecast by Regions (2020-2025)
4.2.2 Global Montelukast Drug Revenue and Forecast by Regions (2020-2025)
4.3 North America Montelukast Drug Market Size and Forecast (2015-2025)
4.4 Europe Montelukast Drug Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Montelukast Drug Market Size and Forecast (2015-2025)
4.6 South America Montelukast Drug Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Montelukast Drug Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Montelukast Drug Market Size by Country (2015-2020)
5.1.1 North America Montelukast Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Montelukast Drug Revenue and Market Share by Country (2015-2020)
5.2 North America Montelukast Drug Market Size and Forecast by Country (2020-2025)
5.2.1 North America Montelukast Drug Sales and Forecast by Country (2020-2025)
5.2.2 North America Montelukast Drug Revenue and Forecast by Country (2020-2025)
5.3 United States Montelukast Drug Market Size and Forecast (2015-2025)
5.4 Canada Montelukast Drug Market Size and Forecast (2015-2025)
5.5 Mexico Montelukast Drug Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Montelukast Drug Market Size by Country (2015-2020)
6.1.1 Europe Montelukast Drug Sales by Country (2015-2020)
6.1.2 Europe Montelukast Drug Revenue by Country (2015-2020)
6.2 Europe Montelukast Drug Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Montelukast Drug Sales and Forecast by Country (2020-2025)
6.2.2 Europe Montelukast Drug Revenue and Forecast by Country (2020-2025)
6.3 Germany Montelukast Drug Market Size and Forecast (2015-2025)
6.4 United Kingdom Montelukast Drug Market Size and Forecast (2015-2025)
6.5 France Montelukast Drug Market Size and Forecast (2015-2025)
6.6 Russia Montelukast Drug Market Size and Forecast (2015-2025)
6.7 Italy Montelukast Drug Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Montelukast Drug Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Montelukast Drug Sales by Region (2015-2020)
7.1.2 Asia-Pacific Montelukast Drug Revenue by Region (2015-2020)
7.2 Asia-Pacific Montelukast Drug Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Montelukast Drug Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Montelukast Drug Revenue and Forecast by Region (2020-2025)
7.3 China Montelukast Drug Market Size and Forecast (2015-2025)
7.4 Japan Montelukast Drug Market Size and Forecast (2015-2025)
7.5 Korea Montelukast Drug Market Size and Forecast (2015-2025)
7.6 India Montelukast Drug Market Size and Forecast (2015-2025)
7.7 Southeast Asia Montelukast Drug Market Size and Forecast (2015-2025)
7.8 Australia Montelukast Drug Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Montelukast Drug Market Size by Country (2015-2020)
8.1.1 South America Montelukast Drug Sales by Country (2015-2020)
8.1.2 South America Montelukast Drug Revenue by Country (2015-2020)
8.2 South America Montelukast Drug Market Size and Forecast by Country (2020-2025)
8.2.1 South America Montelukast Drug Sales and Forecast by Country (2020-2025)
8.2.2 South America Montelukast Drug Revenue and Forecast by Country (2020-2025)
8.3 Brazil Montelukast Drug Market Size and Forecast (2015-2025)
8.4 Argentina Montelukast Drug Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Montelukast Drug Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Montelukast Drug Sales by Country (2015-2020)
9.1.2 Middle East & Africa Montelukast Drug Revenue by Country (2015-2020)
9.2 Middle East & Africa Montelukast Drug Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Montelukast Drug Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Montelukast Drug Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Montelukast Drug Market Size and Forecast (2015-2025)
9.4 Turkey Montelukast Drug Market Size and Forecast (2015-2025)
9.5 Egypt Montelukast Drug Market Size and Forecast (2015-2025)
9.6 South Africa Montelukast Drug Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Montelukast Drug Market Size by Type (2015-2020)
10.1.1 Global Montelukast Drug Sales by Type (2015-2020)
10.1.2 Global Montelukast Drug Revenue by Type (2015-2020)
10.1.3 Global Montelukast Drug Price by Type (2015-2020)
10.2 Global Montelukast Drug Market Size and Forecast by Type (2020-2025)
10.2.1 Global Montelukast Drug Sales and Forecast by Type (2020-2025)
10.2.2 Global Montelukast Drug Revenue and Forecast by Type (2020-2025)
10.2.3 Global Montelukast Drug Price and Forecast by Type (2020-2025)
10.3 United States Montelukast Drug Market Size and Forecast by Type (2015-2025)
10.3.1 United States Montelukast Drug Market Size by Type (2015-2020)
10.3.2 United States Montelukast Drug Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Montelukast Drug Market Size by Application (2015-2020)
11.1.1 Global Montelukast Drug Sales by Application (2015-2020)
11.1.2 Global Montelukast Drug Revenue by Application (2015-2020)
11.1.3 Global Montelukast Drug Price by Application (2015-2020)
11.2 Global Montelukast Drug Market Size and Forecast by Application (2020-2025)
11.2.1 Global Montelukast Drug Sales and Forecast by Application (2020-2025)
11.2.2 Global Montelukast Drug Revenue and Forecast by Application (2020-2025)
11.2.3 Global Montelukast Drug Price and Forecast by Application (2020-2025)
11.3 United States Montelukast Drug Market Size and Forecast by Application (2015-2025)
11.3.1 United States Montelukast Drug Market Size by Application (2015-2020)
11.3.2 United States Montelukast Drug Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Montelukast Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Montelukast Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Montelukast Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Montelukast Drug Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 6. Merck & Co. Montelukast Drug Major Business
Table 7. Merck & Co. Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 8. Merck & Co. SWOT Analysis
Table 9. Merck & Co. Montelukast Drug Product and Services
Table 10. Merck & Co. Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Lannett Company Basic Information, Manufacturing Base and Competitors
Table 12. Lannett Company Montelukast Drug Major Business
Table 13. Lannett Company Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 14. Lannett Company SWOT Analysis
Table 15. Lannett Company Montelukast Drug Product and Services
Table 16. Lannett Company Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 18. Glenmark Pharmaceuticals Montelukast Drug Major Business
Table 19. Glenmark Pharmaceuticals Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 20. Glenmark Pharmaceuticals SWOT Analysis
Table 21. Glenmark Pharmaceuticals Montelukast Drug Product and Services
Table 22. Glenmark Pharmaceuticals Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. Teva Basic Information, Manufacturing Base and Competitors
Table 24. Teva Montelukast Drug Major Business
Table 25. Teva Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 26. Teva SWOT Analysis
Table 27. Teva Montelukast Drug Product and Services
Table 28. Teva Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 30. Torrent Pharmaceuticals Montelukast Drug Major Business
Table 31. Torrent Pharmaceuticals Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 32. Torrent Pharmaceuticals SWOT Analysis
Table 33. Torrent Pharmaceuticals Montelukast Drug Product and Services
Table 34. Torrent Pharmaceuticals Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Mylan Basic Information, Manufacturing Base and Competitors
Table 36. Mylan Montelukast Drug Major Business
Table 37. Mylan Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 38. Mylan SWOT Analysis
Table 39. Mylan Montelukast Drug Product and Services
Table 40. Mylan Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Dr. Reddys Laboratories Basic Information, Manufacturing Base and Competitors
Table 42. Dr. Reddys Laboratories Montelukast Drug Major Business
Table 43. Dr. Reddys Laboratories Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 44. Dr. Reddys Laboratories SWOT Analysis
Table 45. Dr. Reddys Laboratories Montelukast Drug Product and Services
Table 46. Dr. Reddys Laboratories Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Sandoz Basic Information, Manufacturing Base and Competitors
Table 48. Sandoz Montelukast Drug Major Business
Table 49. Sandoz Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 50. Sandoz SWOT Analysis
Table 51. Sandoz Montelukast Drug Product and Services
Table 52. Sandoz Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Hikma Group Basic Information, Manufacturing Base and Competitors
Table 54. Hikma Group Montelukast Drug Major Business
Table 55. Hikma Group Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 56. Hikma Group SWOT Analysis
Table 57. Hikma Group Montelukast Drug Product and Services
Table 58. Hikma Group Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Apotex Basic Information, Manufacturing Base and Competitors
Table 60. Apotex Montelukast Drug Major Business
Table 61. Apotex Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 62. Apotex SWOT Analysis
Table 63. Apotex Montelukast Drug Product and Services
Table 64. Apotex Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 66. Ajanta Pharma Montelukast Drug Major Business
Table 67. Ajanta Pharma Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 68. Ajanta Pharma SWOT Analysis
Table 69. Ajanta Pharma Montelukast Drug Product and Services
Table 70. Ajanta Pharma Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Unichem Laboratories Basic Information, Manufacturing Base and Competitors
Table 72. Unichem Laboratories Montelukast Drug Major Business
Table 73. Unichem Laboratories Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 74. Unichem Laboratories SWOT Analysis
Table 75. Unichem Laboratories Montelukast Drug Product and Services
Table 76. Unichem Laboratories Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 78. Aurobindo Pharma Montelukast Drug Major Business
Table 79. Aurobindo Pharma Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 80. Aurobindo Pharma SWOT Analysis
Table 81. Aurobindo Pharma Montelukast Drug Product and Services
Table 82. Aurobindo Pharma Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 83. Shanghai Anbison Lab Basic Information, Manufacturing Base and Competitors
Table 84. Shanghai Anbison Lab Montelukast Drug Major Business
Table 85. Shanghai Anbison Lab Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 86. Shanghai Anbison Lab SWOT Analysis
Table 87. Shanghai Anbison Lab Montelukast Drug Product and Services
Table 88. Shanghai Anbison Lab Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 89. MACLEODS Basic Information, Manufacturing Base and Competitors
Table 90. MACLEODS Montelukast Drug Major Business
Table 91. MACLEODS Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 92. MACLEODS SWOT Analysis
Table 93. MACLEODS Montelukast Drug Product and Services
Table 94. MACLEODS Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 95. Unimark Basic Information, Manufacturing Base and Competitors
Table 96. Unimark Montelukast Drug Major Business
Table 97. Unimark Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 98. Unimark SWOT Analysis
Table 99. Unimark Montelukast Drug Product and Services
Table 100. Unimark Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 101. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 102. Accord Healthcare Montelukast Drug Major Business
Table 103. Accord Healthcare Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 104. Accord Healthcare SWOT Analysis
Table 105. Accord Healthcare Montelukast Drug Product and Services
Table 106. Accord Healthcare Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 107. Amneal Pharmaceuticals Montelukast Drug Type and Application
Table 108. Amneal Pharmaceuticals Montelukast Drug Major Business
Table 109. Amneal Pharmaceuticals Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 110. Amneal Pharmaceuticals SWOT Analysis
Table 111. Amneal Pharmaceuticals Montelukast Drug Product and Services
Table 112. Amneal Pharmaceuticals Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 113. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 114. Jubilant Pharma Montelukast Drug Major Business
Table 115. Jubilant Pharma Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 116. Jubilant Pharma SWOT Analysis
Table 117. Jubilant Pharma Montelukast Drug Product and Services
Table 118. Jubilant Pharma Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 119. Hetero Basic Information, Manufacturing Base and Competitors
Table 120. Hetero Montelukast Drug Major Business
Table 121. Hetero Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 122. Hetero SWOT Analysis
Table 123. Hetero Montelukast Drug Product and Services
Table 124. Hetero Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 125. Perrigo Basic Information, Manufacturing Base and Competitors
Table 126. Perrigo Montelukast Drug Major Business
Table 127. Perrigo Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 128. Perrigo SWOT Analysis
Table 129. Perrigo Montelukast Drug Product and Services
Table 130. Perrigo Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 131. Cipla Basic Information, Manufacturing Base and Competitors
Table 132. Cipla Montelukast Drug Major Business
Table 133. Cipla Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 134. Cipla SWOT Analysis
Table 135. Cipla Montelukast Drug Product and Services
Table 136. Cipla Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 137. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 138. CSPC Ouyi Pharmaceutical Montelukast Drug Major Business
Table 139. CSPC Ouyi Pharmaceutical Montelukast Drug Total Revenue (USD Million) (2018-2019)
Table 140. CSPC Ouyi Pharmaceutical SWOT Analysis
Table 141. CSPC Ouyi Pharmaceutical Montelukast Drug Product and Services
Table 142. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 143. Global Montelukast Drug Sales by Manufacturer (2018-2019) (K MT)
Table 144. Global Montelukast Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 145. Key Players Montelukast Drug Sales in United States (2018-2019) (K MT)
Table 146. Key Players Montelukast Drug Sales Market Share in United States (2018-2019)
Table 147. Key Players Revenue of Montelukast Drug in United States (2018-2019) (USD Million)
Table 148. Global Montelukast Drug Sales by Regions (2015-2020) (K MT)
Table 149. Global Montelukast Drug Sales Market Share by Regions (2015-2020)
Table 150. Global Montelukast Drug Revenue by Regions (2015-2020) (USD Million)
Table 151. Global Montelukast Drug Sales and Forecast by Regions (2020-2025) (K MT)
Table 152. Global Montelukast Drug Sales Market Share by Regions (2020-2025)
Table 153. Global Montelukast Drug Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 154. Global Montelukast Drug Revenue Market Share by Regions (2020-2025) (USD Million)
Table 155. North America Montelukast Drug Sales by Countries (2015-2020) (K MT)
Table 156. North America Montelukast Drug Sales Market Share by Countries (2015-2020)
Table 157. North America Montelukast Drug Revenue by Countries (2015-2020) (USD Million)
Table 158. North America Montelukast Drug Revenue Market Share by Countries (2015-2020)
Table 159. North America Montelukast Drug Sales by Country (2020-2025) (K MT)
Table 160. North America Montelukast Drug Sales Market Share by Country (2020-2025)
Table 161. North America Montelukast Drug Revenue by Country (2020-2025) (USD Million)
Table 162. North America Montelukast Drug Revenue Market Share by Country (2020-2025)
Table 163. Europe Montelukast Drug Sales by Countries (2015-2020) (K MT)
Table 164. Europe Montelukast Drug Sales Market Share by Countries (2015-2020)
Table 165. Europe Montelukast Drug Revenue by Countries (2015-2020) (USD Million)
Table 166. Europe Montelukast Drug Revenue Market Share by Countries (2015-2020)
Table 167. Europe Montelukast Drug Sales by Country (2020-2025) (K MT)
Table 168. Europe Montelukast Drug Sales Market Share by Country (2020-2025)
Table 169. Europe Montelukast Drug Revenue by Country (2020-2025) (USD Million)
Table 170. Europe Montelukast Drug Revenue Market Share by Country (2020-2025)
Table 171. Asia-Pacific Montelukast Drug Sales by Countries (2015-2020) (K MT)
Table 172. Asia-Pacific Montelukast Drug Sales Market Share by Countries (2015-2020)
Table 173. Asia-Pacific Montelukast Drug Revenue by Countries (2015-2020) (USD Million)
Table 174. Asia-Pacific Montelukast Drug Revenue Market Share by Countries (2015-2020)
Table 175. Asia-Pacific Montelukast Drug Sales by Country (2020-2025) (K MT)
Table 176. Asia-Pacific Montelukast Drug Sales Market Share by Country (2020-2025)
Table 177. Asia-Pacific Montelukast Drug Revenue by Country (2020-2025) (USD Million)
Table 178. Asia-Pacific Montelukast Drug Revenue Market Share by Country (2020-2025)
Table 179. South America Montelukast Drug Sales by Countries (2015-2020) (K MT)
Table 180. South America Montelukast Drug Sales Market Share by Countries (2015-2020)
Table 181. South America Montelukast Drug Revenue by Countries (2015-2020) (USD Million)
Table 182. South America Montelukast Drug Revenue Market Share by Countries (2015-2020)
Table 183. South America Montelukast Drug Sales by Country (2020-2025) (K MT)
Table 184. South America Montelukast Drug Sales Market Share by Country (2020-2025)
Table 185. South America Montelukast Drug Revenue by Country (2020-2025) (USD Million)
Table 186. South America Montelukast Drug Revenue Market Share by Country (2020-2025)
Table 187. Middle East & Africa Montelukast Drug Sales by Countries (2015-2020) (K MT)
Table 188. Middle East & Africa Montelukast Drug Sales Market Share by Countries (2015-2020)
Table 189. Middle East & Africa Montelukast Drug Revenue by Countries (2015-2020) (USD Million)
Table 190. Middle East & Africa Montelukast Drug Revenue Market Share by Countries (2015-2020)
Table 191. Middle East & Africa Montelukast Drug Sales by Country (2020-2025) (K MT)
Table 192. Middle East & Africa Montelukast Drug Sales Market Share by Country (2020-2025)
Table 193. Middle East & Africa Montelukast Drug Revenue by Country (2020-2025) (USD Million)
Table 194. Middle East & Africa Montelukast Drug Revenue Market Share by Country (2020-2025)
Table 195. United States Montelukast Drug Sales by Type (2015-2020) (K MT)
Table 196. United States Montelukast Drug Sales Market Share by Type (2015-2020)
Table 197. United States Montelukast Drug Revenue by Type (2015-2020) (USD Million)
Table 198. United States Montelukast Drug Revenue Market Share by Type (2015-2020)
Table 199. United States Montelukast Drug Sales by Type (2020-2025) (K MT)
Table 200. United States Montelukast Drug Sales Market Share by Type (2020-2025)
Table 201. United States Montelukast Drug Revenue by Type (2020-2025) (USD Million)
Table 202. United States Montelukast Drug Revenue Market Share by Type (2020-2025)
Table 203. Global Montelukast Drug Sales by Application (2015-2020) (K MT)
Table 204. Global Montelukast Drug Sales Market Share by Application (2015-2020)
Table 205. Global Montelukast Drug Revenue by Application (2015-2020) (USD Million)
Table 206. Global Montelukast Drug Revenue Market Share by Application (2015-2020)
Table 207. Global Montelukast Drug Price by Application (2015-2020) (USD/MT)
Table 208. Global Montelukast Drug Sales by Application (2020-2025) (K MT)
Table 209. Global Montelukast Drug Sales Market Share by Application (2020-2025)
Table 210. Global Montelukast Drug Revenue by Application (2020-2025) (USD Million)
Table 211. Global Montelukast Drug Revenue Market Share by Application (2020-2025)
Table 212. Global Montelukast Drug Price by Application (2020-2025) (USD/MT)
Table 213. United States Montelukast Drug Sales by Application (2015-2020) (K MT)
Table 214. United States Montelukast Drug Sales Market Share by Application (2015-2020)
Table 215. United States Montelukast Drug Revenue by Application (2015-2020) (USD Million)
Table 216. United States Montelukast Drug Revenue Market Share by Application (2015-2020)
Table 217. United States Montelukast Drug Sales by Application (2020-2025) (K MT)
Table 218. United States Montelukast Drug Sales Market Share by Application (2020-2025)
Table 219. United States Montelukast Drug Revenue by Application (2020-2025) (USD Million)
Table 220. United States Montelukast Drug Revenue Market Share by Application (2020-2025)
Table 221. Direct Channel Pros & Cons
Table 222. Indirect Channel Pros & Cons
Table 223. Distributors/Traders/ Dealers List
Table 224. Customers of Montelukast Drug
Table 225. Market Opportunities in Next Few Years
Table 226. Market Risks Analysis
Table 227. Market Drivers
List of Figures
Figure 1. Montelukast Drug Picture
Figure 2. Global Montelukast Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Tablet Picture
Figure 4. Chewable tablet Picture
Figure 5. Oral Granules Picture
Figure 6. Montelukast Drug Sales Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Drug store Picture
Figure 9. Others Picture
Figure 10. Global Montelukast Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 11. Global Montelukast Drug Sales Growth Rate (2015-2025) (K MT)
Figure 12. Global Montelukast Drug Sales Market Share by Manufacturer in 2019
Figure 13. Global Montelukast Drug Revenue Market Share by Manufacturer in 2019
Figure 14. Key Players Montelukast Drug Revenue Market Share in United States in 2019
Figure 15. Global Top 5 Montelukast Drug Manufacturer Market Share in 2019
Figure 16. Top 3 Montelukast Drug Players Market Share in United States in 2019
Figure 17. Global Montelukast Drug Revenue Market Share by Regions in 2019
Figure 18. North America Montelukast Drug Sales YoY Growth (2015-2025) (K MT)
Figure 19. North America Montelukast Drug Revenue YoY Growth (2015-2025) (USD Million)
Figure 20. Europe Montelukast Drug Sales YoY Growth (2015-2020) (K MT)
Figure 21. Europe Montelukast Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 22. Asia-Pacific Montelukast Drug Sales YoY Growth (2015-2020) (K MT)
Figure 23. Asia-Pacific Montelukast Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. South America Montelukast Drug Sales YoY Growth (2015-2020) (K MT)
Figure 25. South America Montelukast Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. Middle East & Africa Montelukast Drug Sales YoY Growth (2015-2020) (K MT)
Figure 27. Middle East & Africa Montelukast Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 28. North America Montelukast Drug Sales Market Share by Country in 2019
Figure 29. North America Montelukast Drug Revenue Market Share by Country in 2019
Figure 30. United States Montelukast Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 31. Canada Montelukast Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 32. Mexico Montelukast Drug Market Size and Growth Rate (2015-2020) (USD Million)
Figure 33. Europe Montelukast Drug Revenue Market Share by Country in 2019
Figure 34. Germany Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. United Kingdom Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. France Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Russia Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. Italy Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. Asia-Pacific Montelukast Drug Sales Market Share by Region 2018
Figure 40. Asia-Pacific Montelukast Drug Revenue Market Share by Region 2018
Figure 41. China Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. Japan Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Korea Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. India Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Southeast Asia Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. Australia Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. South America Montelukast Drug Sales Market Share by Country in 2019
Figure 48. South America Montelukast Drug Revenue Market Share by Country in 2019
Figure 49. Brazil Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Argentina Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Saudi Arabia Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Turkey Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Egypt Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. South Africa Montelukast Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. Global Revenue Market Share of Montelukast Drug by Type in 2019
Figure 56. Global Revenue Market Share of Montelukast Drug by Application in 2019
Figure 57. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Merck & Co.
Lannett Company
Glenmark Pharmaceuticals
Teva
Torrent Pharmaceuticals
Mylan
Dr. Reddys Laboratories
Sandoz
Hikma Group
Apotex
Ajanta Pharma
Unichem Laboratories
Aurobindo Pharma
Shanghai Anbison Lab
MACLEODS
Unimark
Accord Healthcare
Amneal Pharmaceuticals
Jubilant Pharma
Hetero
Perrigo
Cipla
CSPC Ouyi Pharmaceutical
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets